| Abstract |
The role of metalloproteinases (MMPs) on the migration and invasion of cancer cells has been correlated with tumor aggressiveness, namely with the up-regulation of MMP-2 and 9. Herein, two pyridine-containing macrocyclic compounds, [15]pyN(5) and [16]pyN(5), were synthesized, chemically characterized and evaluated as potential MMP inhibitors for breast cancer therapy using 3D and 2D cellular models. [15]pyN(5) and [16]pyN(5) (5-20 mu M) showed a marked inhibition of MMPs activity (100\% at concentrations >= 7.5 mu M) when compared to ARP-100, a known MMP inhibitor. The inhibitory activity of [15]pyN(5) and [16]pyN(5) was further supported through in silico docking studies using Goldscore and ChemPLP scoring functions. Moreover, although no significant differences were observed in the invasion studies in the presence of all MMPs inhibitors, cell migration was significantly inhibited by both pyridine-containing macrocycles at concentrations above 5 mu M in 2D cells (p < 0.05). In spheroids, the same effect was observed, but only with [16]pyN(5) at 20 mu M and ARP-100 at 40 mu M. Overall, [15]pyN(5) and [16]pyN(5) led to impaired breast cancer cell migration and revealed to be potential inhibitors of MMPs 2 and 9. |
